Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02829606 · ClinicalTrials.gov registry record · NA
Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02829606 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 8 participants.
The verdict
NCT02829606, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A device has been developed that has eye trackers integrated within the Head Mounted Display (HMD) and can remap text and images around the scotoma in real time to prevent information loss from a central scotoma. It can also carry out other types of image processing such as contrast enhancement and image magnification. The aim of this study is to assess the efficacy of this device on the visual performance of participants suffering from central vision loss, with and without remapping
Interventions
- OTHER small scotoma using Head Mounted Display No re-mapping
- OTHER Large scotoma using Head Mounted Display PLUS re-mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-04 |
| Est. Completion | 2024-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02829606
The ClinicalTrials.gov registry entry for NCT02829606 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which small scotoma using Head Mounted Display No re-mapping is the first listed.
NCT02829606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02829606 about?
NCT02829606 is a clinical study titled "Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)". A device has been developed that has eye trackers integrated within the Head Mounted Display (HMD) and can remap text and images around the scotoma in real time to prevent information loss from a central scotoma. It can also carry out other types of image processing such as contrast enhancement and ...
What is the current status of trial NCT02829606?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-04. Estimated completion is 2024-05.
What interventions are being tested in trial NCT02829606?
The interventions under investigation include: small scotoma using Head Mounted Display No re-mapping (OTHER), Large scotoma using Head Mounted Display PLUS re-mapping (OTHER).
Who is sponsoring clinical trial NCT02829606?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.